Mandelbaum, Rachel S.
Bainvoll, Liat
Violette, Caroline J.
Smith, Meghan B.
Matsuzaki, Shinya
Klar, Maximilian
Ho, Jacqueline R.
Bendikson, Kristin A.
Paulson, Richard J.
Matsuo, Koji http://orcid.org/0000-0002-6232-8701
Funding for this research was provided by:
Ensign Endowment for Gynecologic Cancer Research
Article History
Received: 3 December 2020
Accepted: 12 June 2021
First Online: 9 July 2021
Declarations
:
: All were outside the current work: honorarium, Chugai, textbook editorial expense, Springer, and investigator meeting attendance expense, VBL therapeutics (K.M.); advisory board, Tesaro, GSK (M.K.); research funding, Merck Sharp & Dorme (S.M.); consultant, Ferring (R.J.P.); none for others.
: This article used publicly available deidentified data, and does not contain any studies with human participants performed by any of the authors.
: Not applicable for this study (Ethical Committee Exemption, HS-16-00481).